(Total Views: 696)
Posted On: 06/01/2021 6:38:41 AM
Post# of 716
$NRXP $RLFTF NRx Pharmaceuticals Announces Positive Results for ZYESAMI™ (Aviptadil-acetate) and Submits Emergency Use Authorization Application to US FDA to Treat Critical COVID-19 in Patients Suffering from Respiratory Failure
JUNE 01, 2021 6:28AM
https://ir.nrxpharma.com/news-events/press-re...esults-for
JUNE 01, 2021 6:28AM
https://ir.nrxpharma.com/news-events/press-re...esults-for
(0)
(0)
$MJ
Scroll down for more posts ▼
